Skip to main content

Handelsbanken Fonder AB

Position in ROIV — Roivant Sciences Ltd.

CIK 1398318 STOCKHOLM, V7

Position in ROIV

as of Jun 30, 2026 · filed Jul 10, 2026
Position Value
$6,271,426
+$3,030,277 QoQ
Shares Held
177,209
+51.4% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#128
of 494 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ROIV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Handelsbanken Fonder AB holds $686,434,691 across 88 Biotechnology names. ROIV ranks #21 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ROIV

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,271,426 177,209
2026-03-31 $3,241,149 117,009
2025-12-31 $2,539,095 117,009
2025-09-30 $1,564,578 103,409
2025-06-30 $1,165,419 103,409
2025-03-31 $1,141,269 113,109
2024-12-31 $1,338,079 113,109
2024-09-30 $2,208,859 191,409
2024-06-30 $1,206,132 114,109
2024-03-31 $1,307,054 124,009
2023-12-31 $1,166,898 103,909
2023-09-30 $956,697 81,909
2023-06-30 $675,360 67,000
2023-03-31 $99,630 13,500
2022-12-31 $107,865 13,500